HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cystatin C levels in plasma and peripheral blood mononuclear cells among hyperhomocysteinaemic subjects: effect of treatment with B-vitamins.

Abstract
Homocysteine has been related to increased risk of CVD. Matrix degradation and inflammation may be involved in this link between hyperhomocysteinaemia and CVD. Recent studies suggest that cystatin C can modulate matrix degradation and inflammation. The present study measured cystatin C at protein (plasma) and mRNA levels (peripheral blood mononuclear cells (PBMC)) in hyperhomocysteinaemic individuals (n 37, female seven and male thirty, aged 20-70 years) before and after B-vitamin supplementation for 3 months in a randomised, placebo-controlled double-blind trial. In a cross-sectional study, seventeen of the hyperhomocysteinaemic subjects were age- and sex-matched to healthy controls (n 17). Our main findings were: (i) as compared with controls, hyperhomocysteinaemic subjects tended to have higher plasma concentrations of cystatin C and lower mRNA levels of cystatin C in PBMC; (ii) compared with placebo, treatment of hyperhomocysteinaemic individuals with B-vitamins significantly increased plasma levels of cystatin C and mRNA levels of cystatin C in PBMC; (iii) while plasma levels of cystatin C were positively correlated with plasma levels of TNF receptor-1, mRNA levels of cystatin C in PBMC were inversely correlated with this TNF parameter. Taken together, our findings suggest that disturbed cystatin C levels may be a characteristic of hyperhomocysteinaemic individuals, potentially related to low-grade systemic inflammation in hyperhomocysteinaemic subjects, and that B-vitamins may modulate cystatin C levels in these individuals.
AuthorsKari Anne R Tobin, Kirsten B Holven, Kjetil Retterstøl, Ellen Strøm, Leiv Ose, Pål Aukrust, Marit S Nenseter
JournalThe British journal of nutrition (Br J Nutr) Vol. 102 Issue 12 Pg. 1783-9 (Dec 2009) ISSN: 1475-2662 [Electronic] England
PMID19682403 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Cystatin C
  • Placebos
  • RNA, Messenger
  • Receptors, Tumor Necrosis Factor, Type I
  • Vitamin B Complex
  • Vitamin B 6
  • Folic Acid
  • Vitamin B 12
Topics
  • Adult
  • Aged
  • Cross-Sectional Studies
  • Cystatin C (blood, genetics)
  • Dietary Supplements
  • Double-Blind Method
  • Female
  • Folic Acid (administration & dosage)
  • Humans
  • Hyperhomocysteinemia (blood, drug therapy)
  • Leukocytes, Mononuclear (chemistry)
  • Male
  • Middle Aged
  • Placebos
  • RNA, Messenger (blood)
  • Receptors, Tumor Necrosis Factor, Type I (blood)
  • Vitamin B 12 (administration & dosage)
  • Vitamin B 6 (administration & dosage)
  • Vitamin B Complex (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: